RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED PHASE III STUDY OF WEEKLY ADMINISTRATION OF DARBEPOETIN ALFA IN ANEMIC PATIENTS WITH LUNG OR GYNECOLOGIC CANCER RECEIVING PLATINUM-CONTAINING CHEMOTHERAPY

被引：0
|
作者：
Katsumata, N. [1 ]
Fujiwara, Y. [1 ]
Katakami, N. [2 ]
Nishiwaki, Y. [3 ]
Tsuboi, M. [4 ]
Takeda, K. [5 ]
Nakanishi, T. [6 ]
Ichinose, Y. [7 ]
Kawahara, Y. [8 ]
Hotta, T. [6 ]
Saijo, N. [9 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Inst Biomed Res & Innovat, Kobe, Hyogo, Japan
[3] Natl Canc Ctr Hosp E, Chiba, Japan
[4] Tokyo Med Univ Hosp, Tokyo, Japan
[5] Osaka City Gen Hosp, Osaka, Japan
[6] Nagoya Med Ctr, Natl Hosp Org, Aichi, Japan
[7] Kyushu Canc Ctr, Natl Hosp Org, Fukuoka, Japan
[8] Chuo Chest Med Ctr, Natl Hosp Org Kinki, Osaka, Japan
[9] Kinki Univ, Sch Med, Osaka 589, Japan
来源：
VOX SANGUINIS | 2009年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [21] A Randomized, Double-Blind, Placebo-Controlled, Phase III Noninferiority Study of the Long-Term Safety and Efficacy of Darbepoetin Alfa for Chemotherapy-Induced Anemia in Patients With Advanced NSCLC
    Gascon, Pere
    Nagarkar, Rajnish
    Smakal, Martin
    Syrigos, Konstantinos N.
    Barrios, Carlos H.
    Cardenas Sanchez, Jesus
    Zhang, Li
    Henry, David H.
    Gordon, David
    Hirsh, Vera
    Kubota, Kaoru
    Orlov, Sergey
    Thomas, Gary
    Steinmetz, Tilman
    Kang, Jin-Hyoung
    Tomita, Dianne K.
    Fleishman, Alexander N.
    Park, Joseph K.
    Brandao, Cisio De Oliveira
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : 190 - 202
  • [22] Randomized, double-blind, placebo-controlled study of darbepoetin alfa every 3 weeks for the treatment of chemotherapy-induced anemia
    Taylor, K
    Ganly, P
    Charu, V
    DiBenedetto, J
    Kracht, K
    Rossi, G
    Hernandez, E
    BLOOD, 2005, 106 (11) : 992A - 993A
  • [23] A randomized, double-blind, placebo-controlled phase III study to evaluate weekly intravenous bolus administration of alefacept in patients with chronic plaque psoriasis
    Lebwohl, M
    Bissonnette, R
    Ellis, C
    Gordon, K
    Gottlieb, AB
    Gulliver, W
    Korman, N
    Krueger, G
    Lowe, N
    Menter, A
    Papp, K
    Poulin, Y
    Washenik, K
    Rizova, E
    SKIN AND ENVIRONMENT - PERCEPTION AND PROTECTION, VOLS 1 AND 2, 2001, : 537 - 541
  • [24] Positive epoetin alfa effect on quality of life in anemic cancer patients receiving chemotherapy: Results from a randomized placebo-controlled trial
    Fallowfield, L
    Gagnon, D
    Zagari, M
    Bresnahan, B
    Vercammen, E
    Littlewood, TJ
    McNulty, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S360 - S360
  • [25] Phase III double blind placebo-controlled study of olanzapine for chemotherapy related anorexia in patients with advanced gastric, hepatopancreaticobiliary and lung cancer
    Singuluri, S. L.
    Srinivasan, N.
    Goenka, L.
    Dubashi, B.
    Kayal, S.
    Harichandrakumar, K. T.
    Govindarajalou, R.
    Ganesan, P.
    ANNALS OF ONCOLOGY, 2022, 33 : 1540 - 1540
  • [26] Safety and efficacy of darbepoetin alfa treatment in anemic patients with symptomatic heart failure: a pooled analysis of two randomized, double-blind, placebo-controlled trials
    Abraham, W. T.
    Klapholz, M.
    Anand, I.
    Knusel, B.
    Rosser, D.
    Baker, N.
    Sun, Y.
    Van Veldhuisen, D. J.
    EUROPEAN HEART JOURNAL, 2006, 27 : 166 - 167
  • [27] Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy
    Razzouk, Bassem I.
    Hord, Jeffrey D.
    Hockenberry, Marilyn
    Hinds, Pamela S.
    Feusner, James
    Williams, Denise
    Rackoff, Wayne R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (22) : 3583 - 3589
  • [28] Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy
    Volovat, Constantin
    Bondarenko, Igor M.
    Gladkov, Oleg A.
    Elsaesser, Reiner
    Buchner, Anton
    Bias, Peter
    Mueller, Udo
    SPRINGERPLUS, 2015, 4
  • [29] Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study
    Kotasek, D
    Steger, G
    Faught, W
    Underhill, C
    Poulsen, E
    Colowick, AB
    Rossi, G
    Mackey, J
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (14) : 2026 - 2034
  • [30] A randomized, double-blind, placebo-controlled phase III study to evaluate AK104 plus platinum-containing chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer
    Wu, Xiaohua
    Wang, Jing
    Huang, Yi
    Li, Yuzhi
    Sun, Yang
    Wang, Ke
    Xia, Michelle
    Li, Baiyong
    Liu, Wei
    CANCER RESEARCH, 2022, 82 (12)
12345